Search for: "Downing v. Abbott Laboratories"
Results 61 - 80
of 98
Sort by Relevance
|
Sort by Date
31 Oct 2009, 4:06 pm
October 31, 2009 – A summary review of environmental law settlements, decisions, regulatory actions and lawsuits filed during the past week. [read post]
14 Aug 2009, 1:04 am
Abbott Laboratories, ___ F. [read post]
14 Aug 2009, 1:04 am
Abbott Laboratories, ___ F. [read post]
14 Aug 2009, 1:04 am
Abbott Laboratories, ___ F. [read post]
6 Aug 2009, 6:50 am
Abbott Laboratories, ___ F. [read post]
29 May 2009, 6:32 am
The test laid down in Stone v. [read post]
25 May 2009, 5:20 pm
Some are saying ‘absolutely’ (Peter Zura's 271 Patent Blog) (Patent Docs) US Patents BPAI shuts down dissent in favour of efficiency (Patently-O) (IP Watchdog) BPAI statistics: how many opinions do BPAI judges write? [read post]
21 May 2009, 10:03 am
Regardless of whether we elect John McCain or Barack Obama, my hope is that we can get someone who actually knows a thing...Patent SOS: Inequitable Conduct Reform ASAPNot long ago the United States Court of Appeals for the Federal Circuit issued a decision in Abbott Laboratories v. [read post]
9 Jan 2009, 7:00 am
(IP Think Tank) IEEE patent scorecard for 2008 is out (Innovationpartners) (Peter Zura's 271 Patent Blog) Patent databases: 2008 in review (Patent Librarian's Notebook) New kind codes for republished PCT documents (Patent Librarian’s Notebook) The model changes at PatentFreedom; Matsushita is top troll target (IAM) Patent litigation, the ITC, and hardship in the chip industry (IP finance) Global - Copyright Public domain day 2009 (Creative Commons), (Michael Geist)… [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
21 Nov 2008, 1:36 pm
’ paper by Graeme Clark SC (IP Down Under) Full Federal Court decision concerning brand reputation in context of ‘lookalike’ products and famous brands: Hansen Beverage Company v Bickfords (Australia) Pty Ltd (Mallesons Stephen Jaques) Federal Court holds that grace period applicable to a ‘parent patent’ is different to that of its divisional ‘child’: Mont Adventure Equipment v Phoenix Leisure Group (IP… [read post]
13 Nov 2008, 1:52 pm
Abbott Laboratories, 607 P.2d 924, (Cal. 1980). [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360) Products… [read post]
25 Oct 2008, 12:03 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Biaxin (Clarithromycin) - US: New standard for materiality: Abbott Laboratories v. [read post]
2 Oct 2008, 12:36 pm
Abbott Laboratories, 447 F.3d 861, 867 (5th Cir. 2006), the court blew out this type of claim, finding the defendant's warning about high blood pressure sufficient and that there was no need to go further ant tell doctors about what high blood pressure itself can cause. [read post]
19 Sep 2008, 6:00 pm
: (IPRoo), Giving Goliath the slingshot: Review of the National Innovation System on 'the costs of enforcing IP rights': (Australia & New Zealand Intellectual Property Law), Take patent policy away from lawyers, says Australian government report: (IAM), Advisory Council announces review of scope of patentable subject matter: (International Law Office), Federal Court's flu shot for patent law: Notice to Practitioners - Proceedings under the Patents Act 1990 (Cth): (Australia… [read post]
21 Aug 2008, 3:03 pm
Applying the two-part test established by the Supreme Court in Abbott Laboratories v. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
